168 related articles for article (PubMed ID: 8245882)
1. Potential for combined therapy with 348U87, a ribonucleotide reductase inhibitor, and acyclovir as treatment for acyclovir-resistant herpes simplex virus infection.
Safrin S; Schacker T; Delehanty J; Hill E; Corey L
J Med Virol; 1993; Suppl 1():146-9. PubMed ID: 8245882
[TBL] [Abstract][Full Text] [Related]
2. Topical treatment of infection with acyclovir-resistant mucocutaneous herpes simplex virus with the ribonucleotide reductase inhibitor 348U87 in combination with acyclovir.
Safrin S; Schacker T; Delehanty J; Hill E; Corey L
Antimicrob Agents Chemother; 1993 May; 37(5):975-9. PubMed ID: 8390815
[TBL] [Abstract][Full Text] [Related]
3. Synergistic topical therapy by acyclovir and A1110U for herpes simplex virus induced zosteriform rash in mice.
Lobe DC; Spector T; Ellis MN
Antiviral Res; 1991 Feb; 15(2):87-100. PubMed ID: 1650166
[TBL] [Abstract][Full Text] [Related]
4. Synergistic therapy by acyclovir and A1110U for mice orofacially infected with herpes simplex viruses.
Ellis MN; Lobe DC; Spector T
Antimicrob Agents Chemother; 1989 Oct; 33(10):1691-6. PubMed ID: 2556074
[TBL] [Abstract][Full Text] [Related]
5. Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovir.
Spector T; Lobe DC; Ellis MN; Blumenkopf TA; Szczech GM
Antimicrob Agents Chemother; 1992 May; 36(5):934-7. PubMed ID: 1324641
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.
Duan J; Liuzzi M; Paris W; Lambert M; Lawetz C; Moss N; Jaramillo J; Gauthier J; Déziel R; Cordingley MG
Antimicrob Agents Chemother; 1998 Jul; 42(7):1629-35. PubMed ID: 9660995
[TBL] [Abstract][Full Text] [Related]
7. Solar simulator-induced herpes simplex labialis: use in evaluating treatment with acyclovir plus 348U87.
Bernstein DI; Rheins LA
Antiviral Res; 1994 Apr; 23(3-4):225-33. PubMed ID: 8042862
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
[TBL] [Abstract][Full Text] [Related]
9. Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial.
Hardy WD
Am J Med; 1992 Feb; 92(2A):30S-35S. PubMed ID: 1531285
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus resistance to acyclovir: clinical relevance.
Pottage JC; Kessler HA
Infect Agents Dis; 1995 Sep; 4(3):115-24. PubMed ID: 8548189
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Cafon gel on cutaneous infection with herpes simplex virus (HSV)-2 and acyclovir-resistant HSV in mice.
Yoshida Y; Yamamura J; Sato H; Koyasu M; Obara Y; Sekiguchi H; Kawana T; Shiraki K
J Dermatol Sci; 1996 Dec; 13(3):237-41. PubMed ID: 9023706
[TBL] [Abstract][Full Text] [Related]
13. Recurrent herpes simplex virus hepatitis after liver retransplantation despite acyclovir therapy.
Longerich T; Eisenbach C; Penzel R; Kremer T; Flechtenmacher C; Helmke B; Encke J; Kraus T; Schirmacher P
Liver Transpl; 2005 Oct; 11(10):1289-94. PubMed ID: 16184558
[TBL] [Abstract][Full Text] [Related]
14. The ribonucleotide reductase inhibitor (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731): a potential topical therapy for herpes simplex virus infection.
Bridges CG; Ahmed SP; Sunkara PS; McCarthy JR; Tyms AS
Antiviral Res; 1995 Aug; 27(4):325-34. PubMed ID: 8540753
[TBL] [Abstract][Full Text] [Related]
15. Treatment of acyclovir-resistant herpes simplex virus infections in patients with AIDS.
Safrin S
J Acquir Immune Defic Syndr (1988); 1992; 5 Suppl 1():S29-32. PubMed ID: 1602361
[TBL] [Abstract][Full Text] [Related]
16. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus.
Saijo M; Suzutani T; Itoh K; Hirano Y; Murono K; Nagamine M; Mizuta K; Niikura M; Morikawa S
J Med Virol; 1999 Aug; 58(4):387-93. PubMed ID: 10421406
[TBL] [Abstract][Full Text] [Related]
18. [Resistance of herpes simplex viruses to antiviral drugs].
Scieux C; Bianchi A
Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
[TBL] [Abstract][Full Text] [Related]
19. Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients.
Kakiuchi S; Tsuji M; Nishimura H; Yoshikawa T; Wang L; Takayama-Ito M; Kinoshita H; Lim CK; Fujii H; Yamada S; Harada S; Oka A; Mizuguchi M; Taniguchi S; Saijo M
J Infect Dis; 2017 Mar; 215(6):865-873. PubMed ID: 28453848
[TBL] [Abstract][Full Text] [Related]
20. Relation between herpes simplex viruses and human immunodeficiency virus infections.
Severson JL; Tyring SK
Arch Dermatol; 1999 Nov; 135(11):1393-7. PubMed ID: 10566840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]